Please assess the completion status of the following clinical trial:

Trial Title: Efficacy Parecoxib and Ketorolac as Preemptive Analgesia in Spine Fusion

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Patients undergoing lumbar spinal fusion for one to three levels~* ASA class I or II~Exclusion Criteria:~* History of allergy to Sulfa group~* History of allergy to OPOID or NSAIDs~* Contraindicate to NSAIDs use~* History of coagulopathy or platelet disfunction

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Parecoxib (Type: EXPERIMENTAL): Parecoxib
- Ketorolac (Type: EXPERIMENTAL): Ketorolac
- No medication (Type: NO_INTERVENTION): No medication

Based on this trial design, predict the completion outcome and termination type (if applicable).